James Graf - 01 Dec 2023 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Interim CFO
Signature
/s/ James A. Graf
Issuer symbol
NKGN
Transactions as of
01 Dec 2023
Net transactions value
+$2,172
Form type
4
Filing time
05 Dec 2023, 15:50:10 UTC
Previous filing
22 Nov 2023
Next filing
10 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKGN Common Stock Purchase $737 +220 +957% $3.35 243 01 Dec 2023 Direct F1
transaction NKGN Common Stock Purchase $1,436 +450 +185% $3.19 693 04 Dec 2023 Direct F2
holding NKGN Common Stock 2,436,744 01 Dec 2023 By Graf Acquisition Partners IV LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.31 to $3.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.03 to $3.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 James A. Graf is the managing member of Graf Acquisition Partners IV LLC. Mr. Graf has voting and investment discretion with respect to the securities held of record by Graf Acquisition Partners IV LLC.